fda calls for heartburn drug zantac to be pulled off the market
Published 4 years ago • 6.1K plays • Length 0:26Download video MP4
Download video MP3
Similar videos
-
3:07
new concerns about heartburn drug, chemical linked to cancer
-
10:06
ranitidine recall 2020 - fda calls for removal of all products due to cancer risk
-
1:07
zantac recall continues as fda investigates
-
0:23
zantac recall: fda says carcinogen contamination has lasting affects
-
1:51
zantac pulled off the shelves after fda reports impurity could lead to cancer
-
0:26
fda calls for heartburn drug zantac to be pulled off the market
-
3:00
zantac: heartburn drug ranitidine's possible cancer link investigated
-
9:01
ranitidine (zantac®) cancer scare | products may contain probable cancer-causing substance
-
36:41
nitrosamine in pharmaceutical products? a deep dive into risk management by ron najafi, ph.d.
-
4:37
fda says probable cancer-causing chemical known as ndma in zantac
-
6:39
regulators investigating how a suspected cancer-causing agent got into heartburn drug zantac | 7.30
-
0:27
fda calls on manufactures to pull zantac
-
1:50
fda finds cancer-causing chemical in heartburn medicine zantac
-
4:39
what you need to know about the dangers of zantac
-
2:44
ask dr. nandi: fda finds 'potentially dangerous' cancer-causing contaminant in zantac, related drugs
-
1:07
fda: remove zantac heartburn products
-
1:05
zantac fda recall - laura daly
-
4:14
zantac and its generic version found with chemical that could lead to cancer
-
6:24
zantac (ranitidine) recall and cancer lawsuit
-
0:53
retail giant walmart halts sales of zantac and related drugs
-
1:22
novartis halts distribution of generic heartburn medication
-
7:26
zantac recall: does zantac cause cancer?